DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of fair value and notional amounts of derivative contracts by major product type on a gross basis

The following tables identify the fair value and notional amounts of derivative contracts by major product type on a gross basis for the Company and the Consolidated Funds as of September 30, 2017 and December 31, 2016:  

	As of September 30, 2017								As of December 31, 2016
	Assets				Liabilities				Assets				Liabilities
The Company	Notional(1)		Fair Value		Notional(1)		Fair Value		Notional(1)		Fair Value		Notional(1)		Fair Value
Foreign exchange contracts	$	37,907	$	1,310	$	124,536	$	4,194	$	62,830	$	3,171	$	—	$	—
Total derivatives, at fair value(2)	$	37,907	$	1,310	$	124,536	$	4,194	$	62,830	$	3,171	$	—	$	—

	As of September 30, 2017										As of December 31, 2016
	Assets				Liabilities						Assets				Liabilities
Consolidated Funds	Notional(1)		Fair Value		Notional(1)			Fair Value			Notional(1)		Fair Value		Notional(1)			Fair Value
Foreign exchange contracts	$	—	$	—	$	—		$	—		$	25,304	$	529	$	—		$	—
Other financial instruments	6,071		1,328		(2,368		)	(201		)	3,575		291		(204		)	(2,999		)
Total derivatives, at fair value(3)	6,071		1,328		(2,368		)	(201		)	28,879		820		(204		)	(2,999		)
Other—equity(4)	—		—		—			—			253		24		—			—
Total	$	6,071	$	1,328	$	(2,368	)	$	(201	)	$	29,132	$	844	$	(204	)	$	(2,999	)

(1) Represents the total contractual amount of derivative assets and liabilities outstanding.

(2) As of September 30, 2017, the Company had the right to, but elected not to, offset $1.3 million of its derivative assets and liabilities. As of December 31, 2016, the Company did not have any derivative liabilities to offset its derivative assets.

(3) As of September 30, 2017 and December 31, 2016, the Consolidated Funds offset $0.7 million and $1.4 million of their derivative assets and liabilities, respectively.

(4) Represents the fair value of warrants which are presented as equity securities within investments of the Consolidated Funds in the Condensed Consolidated Statements of Financial Condition.